Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01428882Phase 4Completed
Phase 4, randomised, double-blind trial of midazolam in Procedural sedation (PS). Primary endpoint: Level of Sedation Throughout the Entire Procedure at 1 hour. Started Jun 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01428882.